AEKYUNG CHEMICAL CO., LTD: debt-to-equity, ROE and more
KOSPI, Legal name AEKYUNG CHEMICAL CO., LTD
Latest figures are the FY2025 consolidated summary statements.
Latest fiscal year ratios (computed here)
- Debt/equity
- 94.6%
- Equity ratio
- 51.4%
- ROE
- -0.7%
- Op. margin
- -0.7%
- Rev. growth
- -11.6%
- Interest coverage
- n/a
Condition flags
- Latest operating profit is not above zero, or not reported.
- Operating loss for 1 straight year.
- Total equity is above paid-in capital. Not capital-impaired.
Interest coverage and dividends (OpenDART)
Interest expense and dividends come from DART's OpenDART annual-report filings, not the FSC summary statements used above. The source differs from the other tables on this page.
Interest coverage = operating profit ÷ interest expenseNo interest expense value yet for this company. Most companies fold interest expense into a single finance-costs line on their income statement, so it cannot be pulled out separately. Interest coverage is not computed here.
Dividends, last 3 fiscal years
| Fiscal year | Cash dividend per share | Payout ratio |
|---|---|---|
| 2025 | ₩140 | -137.0% |
| 2024 | ₩281 | 159.1% |
| 2023 | ₩250 | 36.1% |
Cash dividends for 3 straight years (only the 3 years OpenDART returns).
Source values from the OpenDART (금융감독원 전자공시) annual report. Report fiscal year 2025.
Ratios by year (computed here)
Debt-to-equity = total liabilities ÷ total equity × 100Equity ratio = total equity ÷ total assets × 100ROE = net income ÷ year-end total equity × 100Operating margin = operating profit ÷ revenue × 100Revenue growth = (this year − last year) ÷ last year × 100
Computed from the source figures above with these formulas. Where the source's own debt-to-equity differs from ours, both are shown for that year.
| Fiscal year | Debt/equity | Equity ratio | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| FY2021 consolidated | 80.7% | 55.4% | 11.2% | 5.9% | n/a |
| FY2022 consolidated | 69.5% | 59.0% | 8.2% | 4.4% | 38.6% |
| FY2023 consolidated | 77.7% | 56.3% | 4.5% | 2.5% | -17.6% |
| FY2024 consolidated | 83.1% | 54.6% | 1.2% | 0.9% | -8.4% |
| FY2025 consolidated | 94.6% | 51.4% | -0.7% | -0.7% | -11.6% |
Source figures (FSC summary statements)
Amounts are the source values, shortened. A cell reported as zero may be blank in the source, so it is not used in any ratio.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | ₩1.57T | ₩2.18T | ₩1.79T | ₩1.64T | ₩1.45T |
| Operating profit | ₩93.3B | ₩95.1B | ₩45.1B | ₩15.5B | -₩10.2B |
| Pre-tax income | ₩97.6B | ₩92.8B | ₩41.0B | ₩9.3B | ₩5.6B |
| Net income | ₩77.3B | ₩59.4B | ₩33.0B | ₩8.5B | -₩4.9B |
| Total assets | ₩1.24T | ₩1.23T | ₩1.31T | ₩1.36T | ₩1.39T |
| Total liabilities | ₩555.8B | ₩505.9B | ₩572.0B | ₩615.5B | ₩677.9B |
| Total equity | ₩689.1B | ₩728.1B | ₩736.3B | ₩741.0B | ₩716.4B |
| Paid-in capital | ₩24.3B | ₩24.3B | ₩24.3B | ₩24.3B | ₩24.3B |
| Debt/equity (source value) | 80.7% | 69.5% | 77.7% | 83.1% | 94.6% |
Company outline (FSC)
- Market
- KOSPI
- Fiscal year end
- Dec
- Founded
- 2012-09-03
- Listed
- 12/09/17
- Employees
- 716
- Auditor
- 한영회계법인
- Audit opinion
- 적정의견
- Corporate reg. no.
- 1101114951243
- Outline updated
- 2026-09-24
Check the original filings
Read the annual report and audit report before you decide anything. The link opens a DART search for this company's name.
Search DART for 애경케미칼Computed from the Financial Services Commission's company outline and summary statements (data.go.kr). Data as of 2026-09-24.